Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma-Reference-Cited by-同舟云学术

Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma

Published:2017-09-04 Issue:2 Volume:38 Page:278-284
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Tovoli Francesco¹^ORCID,De Lorenzo Stefania²,Samolsky Dekel Boaz G.³^ORCID,Piscaglia Fabio¹^ORCID,Benevento Francesca¹,Brandi Giovanni²^ORCID,Bolondi Luigi¹^ORCID

Affiliation:

1. Unit of Internal Medicine; Department of Medical and Surgical Sciences (DIMEC); University of Bologna; Bologna Italy

2. Unit of Oncology; Department of Experimental, Diagnostic and Specialty Medicine (DIMES); University of Bologna; Bologna Italy

3. Unit of Anesthesiology and Pain Medicine; Department of Medical and Surgical Sciences (DIMEC); University of Bologna; Bologna Italy

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13546/fullpdf

Reference21 articles.

1. The global impact of hepatic fibrosis and end-stage liver disease;Lim;Clin Liver Dis,2008

2. Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in 4929 consecutive autopsies;Graudal;J Intern Med,1991

3. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace;Baffy;J Hepatol,2012

4. Global estimates of cancer prevalence for 27 sites in the adult population in 2008;Bray;Int J Cancer,2013

5. The past, present, and future of cancer incidence in the United States: 1975 through 2020;Weir;Cancer,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival;Gastroenterology Insights;2023-02-12

2. Use of opioids in patients with cancer with hepatic impairment—a systematic review;BMJ Supportive & Palliative Care;2021-09-01

3. Oxycodone/naloxone prolonged‐release tablets in patients with moderate‐to‐severe, chronic cancer pain: Challenges in the context of hepatic impairment;Asia-Pacific Journal of Clinical Oncology;2021-03-03

4. Endogenous Opiates and Behavior: 2018;Peptides;2020-10

5. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation;Medicinal Research Reviews;2020-06-11